Inhaler to deliver powerful anti-flu drugs
A new dry power inhaler has been developed to deliver potent anti-influenza drug treatments that last longer and require only a single dose.
Archives for March 7, 2007
Bio-Rad launches protein interaction analyser
Bio-Rad launched a new instrument at Pittcon last week that allows the analysis of up to 36 protein-protein interactions in one rapid experiment.
Asterand, Laureate Pharma, PPD and Kendle - People on the move
Asterand, Laureate Pharma, PPD and Kendle have all had people on the move in the world of pharmaceutical outsourcing this past week.
In-Pharma Technologist Special Feature
Focus on: radio frequency identification (RFID) technology
In-PharmaTechnologist takes an indepth look at the new radio frequency identification (RFID) technology that will soon revolutionise pharmaceutical supply chain management.
GSK denies Russian drug trial allegations
GlaxoSmithKline (GSK) has denied allegations that some of its vaccines have been tested illegally and against good clinical practice (GCP) in children in Russia.
New drug battles 'silent killer'
The first new type of high blood pressure medicine in more than a decade has been approved in the US, with experts predicting blockbuster success.
Second generation HIV drug enters clinical trials
The second generation of a new class of HIV drugs have entered clinical trials and could prove more difficult for HIV to develop resistance to, according to developers Panacos.
Liposome technology to help DNAi-based cancer drug delivery
Biotech company ProNAi Therapeutics plans to use a new liposome technology to help deliver its new class of DNA interference (DNAi)-based drug.
Drugs moving into the clinic: 6
The sixth in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators.
New child-proof blisters
Alcoa Flexible Packaging has introduced a range of new child-resistant blister-lidding packaging solutions for the pharmaceutical market.
GSK ramping up drug production in Poland
UK drug goliath GlaxoSmithKline (GSK) is ramping up drug production at its Polish site as it prepares to more than double the number of markets the plant will supply.